Neoadjuvant and Adjuvant Checkpoint Blockade

NCT02519322 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Melanoma
Mucosal Melanoma
Ocular Melanoma
Stage III Acral Lentiginous Melanoma AJCC v7
Stage IIIB Cutaneous Melanoma AJCC v7
Stage IIIB Uveal Melanoma AJCC v7
Stage IIIC Cutaneous Melanoma AJCC v7
Stage IIIC Uveal Melanoma AJCC v7
Stage IV Acral Lentiginous Melanoma AJCC v6 and v7
Stage IV Cutaneous Melanoma AJCC v6 and v7
Stage IV Uveal Melanoma AJCC v7

Interventions

BIOLOGICAL: Ipilimumab
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Nivolumab
BIOLOGICAL: Relatlimab
PROCEDURE: Therapeutic Conventional Surgery

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]